Commentary|Podcasts|December 18, 2024

The Path Forward for Infused Biosimilars in the US

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.

In this exclusive PC Podcast interview, Vibhu Tewary, project director, IQVIA Institute for Human Data Science, discusses:

  • Highlights of the company’s report surrounding the “Long-term Market Sustainability for Infused Biosimilars in the US: Foundational Analytics on Emerging Risks to Sustainability”
  • The process that constructing and piecing together a report of this magnitude entails, along with where the idea itself came from
  • The concept of net cost recovery
  • The ongoing challenges surrounding ASP-based reimbursement
  • A closed-door, multi-stakeholder virtual roundtable (based on his original report) that was previously held

The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!

Related Content